AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

AstraZeneca Ph AstraZeneca Pharma Ltd. | BSE 8850.00 -0.60 (-0.01%) | NSE 8849.00 0.00 (0.00%) | Trade | Add

BSE Live

Feb 27, 15:40

8850.00 -0.60 (-0.01%)

Volume

AVERAGE VOLUME

5-Day

177

10-Day

260

30-Day

360

163

Prev. Close

8850.60
Open Price

8838.95

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 27, 15:56

8849.00 0.00 (0.00%)

Volume

AVERAGE VOLUME

5-Day

4,426

10-Day

4,352

30-Day

7,064

3,340

Prev. Close

8849.00
Open Price

8805.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
8849.00 (15)

Financials

Print/Copy to Excel : Go

Balance Sheet of AstraZeneca Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	5.00	5.00	5.00	5.00	5.00
Total Share Capital	5.00	5.00	5.00	5.00	5.00
Reserves and Surplus	359.44	295.80	241.93	217.87	151.01
Total Reserves and Surplus	359.44	295.80	241.93	217.87	151.01
Total Shareholders Funds	364.44	300.80	246.93	222.87	156.01
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	9.30	0.00	0.00	0.00	1.27
Long Term Provisions	5.38	2.02	6.66	2.28	0.00
Total Non-Current Liabilities	14.68	2.02	6.66	2.28	1.27
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.00
Trade Payables	209.72	168.20	95.34	87.66	94.63
Other Current Liabilities	73.16	56.21	76.63	75.23	120.73
Short Term Provisions	44.36	34.57	34.98	27.45	33.08
Total Current Liabilities	327.24	258.98	206.95	190.34	248.44
Total Capital And Liabilities	706.36	561.80	460.54	415.49	405.72
ASSETS
NON-CURRENT ASSETS
Tangible Assets	71.53	74.83	75.46	86.84	97.36
Intangible Assets	0.00	0.00	0.00	0.00	0.00
Capital Work-In-Progress	24.24	6.90	3.57	4.81	6.31
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	95.77	81.73	79.03	91.65	103.67
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	14.64	23.36	32.55	40.22	0.00
Long Term Loans And Advances	3.90	2.86	2.64	2.87	33.16
Other Non-Current Assets	49.73	49.13	25.40	29.20	0.61
Total Non-Current Assets	164.04	157.08	139.62	163.94	137.44
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	165.15	118.10	113.15	57.71	76.73
Trade Receivables	83.21	79.75	54.63	43.00	84.36
Cash And Cash Equivalents	252.52	173.30	125.92	115.58	76.83
Short Term Loans And Advances	0.80	0.81	1.24	1.22	27.64
OtherCurrentAssets	40.64	32.76	25.98	34.04	2.73
Total Current Assets	542.32	404.72	320.92	251.55	268.28
Total Assets	706.36	561.80	460.54	415.49	405.72
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	69.19	32.57	11.85	17.25	42.75
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	16.20
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.15
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	308.00	196.33	201.49	0.00	4.15
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	30.50	23.62	29.96	--	9.70
BONUS DETAILS
Bonus Equity Share Capital	2.50	2.50	2.50	2.50	2.50
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	0.01
Non-Current Investments Unquoted Book Value	--	--	--	--	--
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--